Drug Targets
These represent specific biological components that a medicinal compound can interact with to modify a disease process or produce a therapeutic effect.
In pharmacology, these are the precise molecular entities, such as proteins or receptors, that serve as the site of action for a potential treatment. By binding to or inhibiting these components, a drug can physically alter cellular behavior to correct pathological functions. Identifying these specific points is critical because it allows researchers to move from broad symptoms to precise interventions that stabilize cellular homeostasis. Without well-defined targets, medications may lack efficacy or cause significant off-target side effects. This differs from biomarkers, which serve as indicators of disease presence rather than the actual sites of medicinal intervention. Also abbreviated as DT.
Appears in articles
From Galactic Voids to Neural Networks: Mapping the Frontiers of Risk and Reality
The article explores diverse scientific frontiers, from 3D mapping of dynamic interstellar space and the genetic architecture of Alzheimer's disease to the discovery of unique bacterial defense mechanisms and AI-driven problem prioritization.